middl
east
respiratori
syndrom
mer
first
emerg
saudi
arabia
remain
global
health
concern
object
studi
compar
clinic
featur
risk
factor
advers
outcom
patient
rtpcr
confirm
mer
acut
respiratori
diseas
merscov
neg
present
king
fahad
medic
citi
kfmc
riyadh
octob
may
demograph
clinic
laboratori
characterist
clinic
outcom
patient
rtpcr
confirm
merscov
infect
compar
test
neg
merscov
pcr
health
care
worker
hcw
mer
compar
mer
patient
health
care
worker
one
hundr
fifti
nine
patient
elig
inclus
forti
eight
test
posit
mer
cov
hospit
acquir
infect
hcw
merscov
neg
patient
acut
respiratori
ill
includ
studi
neg
control
patient
confirm
merscov
infect
clinic
distinguish
neg
merscov
rtpcr
result
although
diarrhoea
common
mer
patient
high
level
suspicion
initi
laboratori
test
merscov
therefor
indic
variabl
associ
advers
outcom
older
age
diabet
comorbid
ill
interestingli
comorbid
ill
diabet
significantli
associ
poor
outcom
health
care
worker
mer
markedli
better
clinic
outcom
compar
non
hcw
mer
patient
mer
coronaviru
merscov
initi
identifi
male
sever
progress
fatal
pneumonia
jeddah
saudi
arabia
june
juli
patient
confirm
merscov
infect
global
fatal
mer
still
remain
zoonot
infect
dromedari
camel
suspect
sourc
infect
howev
transmiss
human
occur
within
famili
health
care
set
lead
hundr
infect
occur
jeddah
riyadh
republ
korea
outbreak
within
health
care
facil
associ
low
clinic
suspicion
delay
recognit
lead
unsuspect
secondari
transmiss
factor
predispos
transmiss
event
includ
overcrowd
emerg
room
lack
effect
triag
first
contact
health
care
system
defici
routin
infect
control
practic
mild
unrecognis
infect
especi
among
health
care
worker
hcw
result
outbreak
earlier
studi
attempt
describ
clinic
featur
mer
well
compar
sar
howev
still
pauciti
data
compar
clinic
present
mer
patient
suspect
mer
test
merscov
neg
inform
whether
clinic
demograph
epidemiolog
characterist
distinguish
mer
caus
acut
respiratori
ill
ari
import
clinician
provid
care
merscov
endem
countri
saudi
arabia
care
travel
return
mersendem
area
one
studi
patient
mer
compar
concurr
investig
patient
rtpcr
neg
mer
furthermor
report
clinic
present
mer
hcw
could
identifi
previou
studi
compar
clinic
featur
merscov
infect
health
care
worker
nonhealth
care
worker
address
gap
knowledg
studi
sought
analys
demograph
characterist
clinic
data
outcom
patient
meet
case
definit
mer
major
hospit
riyadh
test
rtpcr
merscov
clinic
featur
outcom
virolog
confirm
merscov
posit
neg
compar
addit
compar
merscov
posit
hcw
merscov
posit
nonhcw
molecular
epidemiolog
subset
patient
previous
report
studi
conduct
king
fahad
medic
centr
kfmc
tertiari
care
hospit
riyadh
compris
four
hospit
main
women
special
children
rehabilit
main
hospit
hous
four
affili
centr
nation
neurosci
institut
comprehens
cancer
diabet
endocrin
addit
medic
surgic
specialti
depart
within
campu
intens
care
unit
icu
locat
main
hospit
medic
citi
serv
tertiari
referr
centr
patient
throughout
kingdom
includ
studi
patient
met
clinic
case
definit
mer
test
rtpcr
merscov
rna
octob
may
confirm
case
mer
defin
ministri
health
saudi
arabia
febril
patient
ari
test
posit
merscov
infect
patient
communityor
nosocomiallyacquir
mer
well
hcw
diagnos
mer
kfmc
includ
patient
meet
clinic
case
definit
time
frame
merscov
neg
serv
control
nasopharyng
swab
lower
respiratori
tract
specimen
tracheal
aspir
bronchoalveolar
lavag
collect
patient
meet
clinic
case
definit
mer
test
presenc
merscov
rna
octob
april
sampl
test
merscov
moh
laboratori
end
april
inhous
merscov
test
capabl
develop
sampl
test
kfmc
rtpcr
diagnosi
merscov
base
recommend
test
upstream
use
confirm
patient
demograph
clinic
data
retriev
electron
health
record
via
retrospect
chart
review
compar
variou
characterist
among
merscov
posit
hcw
merscov
posit
nonhcw
merscov
neg
case
fisher
exact
test
categor
factor
anova
continu
factor
look
factor
associ
poor
outcom
admiss
icu
death
among
mer
patient
compar
factor
patient
poor
versu
favour
outcom
fisher
exact
test
anova
addit
look
factor
associ
death
mer
patient
fit
logist
regress
investig
time
hospit
admiss
death
among
subgroup
fit
kaplanmei
curv
compar
subgroup
logrank
test
studi
approv
king
fahad
medic
citi
institut
review
board
given
outbreak
situat
waiv
requir
individu
inform
consent
demograph
characterist
elig
patient
review
forti
eight
patient
confirm
merscov
rtpcr
posit
neg
merscov
rtpcr
test
tabl
mer
patient
hospit
acquir
hcw
health
care
worker
mer
like
expatri
merscov
infect
nonhcw
p
merscov
neg
p
patient
howev
differ
nonhcw
merscov
posit
merscov
neg
patient
regard
hcw
mer
philippin
one
malaysia
one
india
although
merscov
posit
patient
overal
like
femal
vs
p
nonhcw
merscov
posit
patient
significantli
differ
regard
merscov
neg
patient
vs
p
mer
patient
nonhcw
like
older
median
age
year
nonmer
patient
median
age
year
p
hcw
mer
patient
median
age
year
p
non
hcw
mer
patient
person
attend
hospit
emerg
room
admit
reason
acquir
infect
within
hospit
histori
exposur
anim
camel
dog
poultri
common
merscov
posit
patient
overal
compar
merscov
neg
patient
p
tabl
histori
exposur
ill
person
health
care
set
two
week
prior
onset
ill
frequent
nonhcw
merscov
posit
merscov
neg
patient
p
present
clinic
featur
comorbid
merscov
posit
hcw
nonhcw
merscov
neg
patient
shown
tabl
compar
merscov
posit
hcw
nonhcw
neg
patient
similar
clinic
present
comorbid
except
diarrhoea
frequent
merscov
posit
cohort
frequenc
report
diarrhoea
merscov
posit
hcw
merscov
posit
nonhcw
merscov
neg
patient
group
respect
statist
signific
differ
observ
frequenc
diarrhoea
compar
merscov
posit
patient
either
hcw
nonhcw
merscov
neg
patient
p
within
merscov
posit
cohort
short
breath
tachycardia
underli
comorbid
cancer
diabet
hypertens
heart
diseas
significantli
frequent
amongst
nonhcw
hcw
biochem
haematolog
paramet
three
group
similar
except
higher
white
blood
count
wbc
valu
merscov
neg
patient
higher
serum
creatinin
level
merscov
posit
nonhcw
compar
mer
neg
patient
tabl
signific
differ
laboratori
paramet
merscov
posit
hcw
nonhcw
among
patient
confirm
mer
chest
radiographi
avail
review
normal
chest
radiograph
initi
present
unilater
lung
infiltr
bilater
lung
infiltr
seven
total
cohort
never
develop
infiltr
amongst
normal
initi
radiograph
deterior
develop
unilater
bilater
infiltr
respect
amongst
patient
baselin
unilater
infiltr
progress
develop
bilater
infiltr
chang
two
patient
bilater
infiltr
surviv
lung
revert
normalci
tabl
among
patient
merscov
infect
poor
clinic
outcom
icu
admiss
death
significantli
associ
older
age
presenc
comorbid
condit
lower
lymphocyt
count
higher
neutrophil
count
higher
serum
creatinin
higher
serum
ldh
level
univari
analysi
tabl
diabet
comorbid
condit
strongli
associ
advers
outcom
p
multivari
regress
analysi
factor
remain
associ
decreas
risk
death
younger
age
hcw
tabl
use
kaplanmei
analysi
surviv
shown
significantli
differ
patient
merscov
infect
taken
togeth
comparison
merscov
neg
patient
fig
upper
panel
merscov
posit
patient
stratifi
hcw
nonhcw
former
better
clinic
outcom
compar
nonhcw
p
fig
lower
panel
mer
posit
nonhcw
wors
outcom
mer
neg
patient
p
surviv
time
significantli
differ
merscov
posit
hcw
merscov
neg
patient
p
surviv
analysi
confirm
mer
patient
without
comorbid
markedli
better
surviv
diabet
p
signific
differ
compar
patient
comorbid
tabl
comparison
laboratori
paramet
among
three
patient
group
diabet
p
final
mer
patient
diabet
significantli
wors
surviv
comorbid
diabet
p
fig
clinic
demograph
outcom
data
patient
investig
suspect
mer
analys
virolog
confirm
merscov
infect
mer
patient
hcw
older
hcw
merscov
neg
present
clinic
featur
patient
mer
indistinguish
investig
mer
found
merscov
neg
except
diarrhoea
common
patient
mer
appear
primarili
hcw
mer
report
diarrhoea
significantli
often
patient
merscov
neg
p
howev
differ
frequenc
diarrhoea
nonhcw
mer
patient
nonmer
patient
notabl
diarrhoea
also
promin
featur
sar
evid
viru
replic
intestin
epithelium
import
note
patient
normal
chest
radiograph
initi
present
never
develop
infiltr
reminisc
radiolog
present
sar
proport
patient
also
infiltr
chest
radiographi
present
mani
detect
abnorm
computeris
tomographi
scan
observ
clinic
featur
patient
merscov
infect
indistinguish
hospitalis
ari
emphasis
need
low
threshold
clinic
suspicion
initi
merscov
laboratori
test
patient
sever
respiratori
diseas
exposur
hospit
environ
two
week
prior
clinic
onset
one
signific
risk
factor
infect
howev
patient
merscov
posit
also
similar
exposur
health
care
facil
possibl
mani
comorbid
exposur
anim
though
significantli
common
report
non
hcw
patient
mer
without
mer
elicit
major
patient
mer
merscov
infect
hcw
nonhcw
known
acquir
nosocomi
thu
would
expect
zoonot
exposur
sourc
infect
patient
mer
nonhcw
like
year
age
compar
nonmer
patient
p
mer
patient
hcw
p
patient
mer
nonhcw
significantli
wors
clinic
outcom
merscov
neg
hcw
merscov
infect
may
relat
part
fact
hcw
nonmer
patient
group
younger
fewer
comorbid
condit
previou
report
merscov
infect
hcw
detect
activ
case
find
contact
seven
infect
hcw
document
two
asymptomat
five
mild
upper
respiratori
tract
symptom
age
hcw
merscov
infect
rang
year
one
underli
comorbid
requir
icu
admiss
one
die
case
seri
mer
signific
proport
hcw
clinic
featur
hcw
non
hcw
mer
patient
systemat
compar
clear
overal
clinic
present
outcom
hcw
nonhcw
mer
markedli
differ
analys
clinic
outcom
mer
import
distinguish
hcw
nonhcw
markedli
differ
clinic
outcom
take
mer
patient
togeth
variabl
associ
poor
clinic
outcom
univari
analysi
older
age
presenc
comorbid
ill
neutrophilia
lower
lymphocyt
count
higher
serum
creatinin
level
higher
serum
ldh
level
multivari
regress
analysi
occup
hcw
younger
age
significantli
associ
favour
clinic
outcom
surviv
analysi
mer
patient
diabet
without
comorbidit
wors
surviv
mer
patient
comorbid
diabet
comorbid
interestingli
patient
comorbid
diabet
significantli
differ
comorbid
limit
studi
includ
possibl
patient
merscov
may
miss
fals
neg
rtpcr
result
may
categoris
nonmerscov
patient
convalesc
sera
avail
test
patient
investig
secondli
data
collect
retrospect
viral
load
data
avail
analysi
mer
neg
case
like
heterogen
diagnosi
final
discharg
diagnosi
control
group
unfortun
avail
conclus
mer
could
reliabl
distinguish
patient
mer
neg
clinic
demograph
epidemiolog
criteria
highlight
need
high
index
suspicion
earli
isol
earli
laboratori
test
identifi
infect
patient
prevent
nosocomi
spread
import
observ
studi
hcw
mer
markedli
favour
clinic
outcom
compar
mer
patient
nonhcw
primarili
younger
less
comorbid
clinic
progress
present
outcom
differ
two
group
kept
mind
adjust
therapeut
trial
mer
design
diabet
rather
comorbid
signific
advers
impact
surviv
